Internal Medicine · Beverly Hills, CA
NPI
1033145701
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
9301 Wilshire Blvd, Suite 512
Beverly Hills, CA, 90210
Phone (310) 657-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$712K
5,916 services
Medicare patients, 2024
460
Average age 78
Drug cost, 2024
$8.2M
38,652 prescriptions
Company payments, 2025
$2,987
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Homayoun Sharim was code 99213 (office e&m - established), 1,955 times for 399 patients. In total Homayoun Sharim billed 5,916 services in 48 codes, and Medicare paid $712K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,955 | 399 | $72.79 | $142K |
| 93000 Electrocardiogram | Office | 577 | 316 | $11.25 | $6,490 |
| 99212 Office E&M - Established | Office | 542 | 279 | $44.42 | $24K |
| 99214 Office E&M - Established | Office | 461 | 284 | $98.35 | $45K |
| 93970 Duplex Scan - Extremity Veins | Office | 296 | 169 | $167.25 | $50K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 215 | 215 | $127.46 | $27K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 200 | 200 | $19.17 | $3,835 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 195 | 195 | $19.17 | $3,738 |
| 36465 Varicose Vein Ablation | Office | 188 | 56 | $1,173.03 | $221K |
| 93306 Echocardiography (TTE/TEE) | Office | 181 | 179 | $160.17 | $29K |
| 36410 Vascular | Office | 163 | 134 | $14.01 | $2,283 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 130 | 129 | $157.03 | $20K |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 107 | 104 | $94.81 | $10K |
| 36475 Varicose Vein Ablation | Office | 76 | 33 | $948.47 | $72K |
| 93925 Duplex Scan - Extremity Arteries | Office | 74 | 73 | $199.49 | $15K |
By year: 2022 $904K for 7,824 services; 2023 $764K for 6,591 services; 2024 $712K for 5,916 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 29 | 26 | $8.40 | $244 |
Medicare prescription drug claims, 2024
In 2024, the drug Homayoun Sharim prescribed most often to Medicare patients was Rosuvastatin Calcium, with 2,018 prescriptions and refills. In total Homayoun Sharim wrote 38,652 Medicare prescriptions that cost $8.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 2,018 | 2,913 | 319 | $12K |
| Vascepa Icosapent Ethyl | 1,152 | 1,351 | 192 | $461K |
| Dexlansoprazole Dr Dexlansoprazole | 853 | 983 | 134 | $161K |
| Metoprolol Succinate Generic | 773 | 1,076 | 124 | $4,952 |
| Amlodipine Besylate Generic | 698 | 906 | 107 | $1,185 |
| Tamsulosin Hcl Generic | 637 | 944 | 110 | $4,148 |
| Levothyroxine Sodium Generic | 600 | 794 | 81 | $3,581 |
| Olmesartan Medoxomil Generic | 590 | 887 | 98 | $4,475 |
| Jardiance Empagliflozin | 589 | 745 | 89 | $423K |
| Metformin Hcl Generic | 585 | 768 | 93 | $1,420 |
| Atorvastatin Calcium Generic | 578 | 774 | 78 | $1,644 |
| Omeprazole Generic | 551 | 743 | 100 | $1,965 |
| Icosapent Ethyl Generic | 544 | 613 | 120 | $103K |
| Linzess Linaclotide | 536 | 598 | 78 | $315K |
| Diclofenac Sodium Generic | 516 | 553 | 129 | $219K |
Brand drugs: 10,301 claims; generic drugs: 28,118 claims; opioid claims: 206.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Homayoun Sharim $2,987 ($2,987 in general payments such as food, travel and fees) from 24 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $349.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $349 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $277 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $271 |
| Amgen Inc. AMGN | 8 | $248 |
| CVRx, Inc. CVRX | 2 | $221 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $191 |
| Madrigal Pharmaceuticals MDGL | 3 | $185 |
| Ardelyx, Inc. ARDX | 8 | $180 |
| Esperion Therapeutics, Inc. ESPR | 11 | $172 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $154 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.